Cardiff Oncology OverviewCardiff Oncology EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CRDF.
Quarterly EBIT
-$12.85M
↑ 10.65% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$46.82M
↑ 10.14% YoY
Trailing 12 months ending Mar 31, 2026
Cardiff Oncology OverviewEBIT (Earnings Before Interest and Taxes) analysis for CRDF.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026